We're Keeping An Eye On TScan Therapeutics' (NASDAQ:TCRX) Cash Burn Rate
We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares since ...